The global sinus dilation devices market size was estimated to be USD 3.06 billion in 2023 and is expected to reach at USD 8.43 billion by 2034 with a CAGR of 9.65% during the forecast period 2024-2034. Increasing preference for minimally invasive procedures, rising favorable reimbursement policies, growing awareness of the benefits of balloon sinuplasty compared to traditional techniques, surge in incidence of chronic sinusitis, increasing advancements in surgical technologies such as laser technologies, rising number of surgeries, growing technological advancements, and surge in launch of advanced sinus dilation devices are some of the key factors boosting the market growth.
Surge in launch of advanced sinus dilation devices is predicted to boost the market growth during the forecast period. The introduction of advanced surgical techniques contributes to enhanced market dynamics by replacing traditional procedures. Hence, these product launches contribute to increased availability and demand, thereby stimulating market growth. In March 2022, Medtronic plc has unveiled the NuVent Eustachian tube dilation balloon, which has received clearance from the U.S. Food and Drug Administration (FDA) for addressing chronic, obstructive Eustachian Tube Dysfunction. The NuVent balloon allows surgeons to administer treatment in either an outpatient or office environment.
By product, balloon sinus dilation (BSD) devices was the highest revenue-grossing segment in the global sinus dilation devices market in 2023 owing to the growing adoption of balloon sinus dilation procedures, an increase in the incidence of sinus infections, advancements in technology, ongoing research and development activities, and a rise in regulatory approvals. For instance, in May 2022, Dalent Medical has obtained additional patent coverage for its Sinusleeve balloon device, providing further safeguarding for the company's exclusive device and technique employed in balloon sinus dilation procedures aimed at treating chronic sinusitis. Additionally, functional endoscopic sinus surgery (FESS) instruments set is predicted to grow at fastest CAGR during the forecast period. The procedure is designed to address recurrent acute rhinosinusitis and medically refractory chronic rhinosinusitis, both with or without polyps. Known for its minimally invasive nature, it is widely preferred over alternative procedures, contributing to the anticipated growth of this segment.
By type, sinuscopes was the highest revenue-grossing segment in the global sinus dilation devices market in 2023 owing to the increasing favouritism towards minimally invasive procedures and advancements in sinuscope technology. Additionally, rhinoscopes is predicted to grow at fastest CAGR during the forecast period owing to the growing technological developments and surge in launch of advanced devices. For instance, in February 2023, Innovia Medical is pleased to introduce the Summit Medical ENT product line in the United Kingdom. This range includes a variety of high-quality essentials such as Grommets and Ventilation Tubes, Rhino Rocket, AbsorbENT Nasal and Sinus Packs, and Denver Splint. Healthcare providers in clinics and hospitals across the United States frequently use these products.
By procedure, standalone was the highest revenue-grossing segment in the global sinus dilation devices market in 2023 owing to the growing inclination toward minimally invasive surgical procedures is attributed to the increased adoption of health insurance. Balloon sinus ostial dilation is conducted independently as a standalone procedure, proving to be as effective as functional endoscopic sinus surgery in treating chronic rhinosinusitis. Additionally, hybrid is predicted to grow at fastest CAGR during the forecast period owing to the rising inclination toward hybrid procedures for both adult and pediatric patients, and an increase in regulatory approvals. For instance, in Aug 2022, Acclarent Inc, a subsidiary of Johnson & Johnson Medical Devices specializing in minimally invasive ENT technologies, has received clearance from the U.S. Food and Drug Administration for its TruDi shaver blade. TruDi is a single-use blade with electromagnetic navigation capabilities, designed for the removal or incision of tissues or bones in the field of Ear, Nose, and Throat (ENT).
By application, adult was the highest revenue-grossing segment in the global sinus dilation devices market in 2023 owing to the high incidence of sinusitis in adults, and increasing mergers & acquisitions among market players. For instance, in May 2022, Medtronic has finalized the acquisition of Intersect ENT, enhancing its ear, nose, and throat (ENT) portfolio with innovative products utilized in sinus procedures. Additionally, pediatric is predicted to grow at fastest CAGR during the forecast period owing to the growing occurrence of sinusitis among children, and various market players are concentrating on the development of products specifically tailored for pediatric patients.
By end-user, hospitals was the highest revenue-grossing segment in the global sinus dilation devices market in 2023 owing to the high volume of surgical procedures, attributed to factors such as the increasing prevalence of chronic sinusitis, favorable reimbursement criteria, the presence of technologically advanced infrastructure and medical equipment enabling the performance of complex sinus surgeries, and a rise in funding from major market players. For instance, in May 2022, The NHS has declared a MedTech funding mandate to enhance the availability and affordability of specific medical devices for patients. Among the supported products in this initiative is the XprESS multi-sinus dilation system by Stryker. This strategic support aims to encourage the adoption of this technology, granting the company a competitive edge in the European market. This initiative not only facilitates broader distribution of Stryker's dilation devices but also reinforces the company's brand presence. Additionally, ambulatory surgical centers (ASCs) is anticipated to grow at fastest CAGR during the forecast period. The healthcare system is showing interest in Ambulatory Surgical Centers (ASCs) as a strategic choice for providing surgical services. Minimally invasive procedures, including Balloon Sinus Dilation (BSD), can be conveniently performed in ASCs. Additionally, the anticipation of cost-effectiveness and more favorable reimbursement scenarios compared to hospitals is expected to drive the growth of this segment.
North America region is anticipated for the highest revenue share during the forecast period owing to the existence of a well-established healthcare infrastructure, a substantial burden of sinusitis and associated diseases, the introduction of new products, a heightened prevalence of risk factors contributing to sinusitis, including increased tobacco use and smoking, and a notable increase in approvals by regulatory authorities. For instance, in July 2022, Zsquare, a company specializing in high-performance, disposable endoscopes, has obtained FDA 510K clearance for its inaugural product, the Zsquare ENT-Flex Rhinolaryngoscope. The company intends to conduct a pilot launch of this product in prominent hospitals and physician practice offices across the United States by the fourth quarter of 2022. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the healthcare infrastructure that is both highly regulated and well-developed, a notable increase in patient awareness regarding sinus surgical procedures, continuous technological advancements, and a growing number of regulatory approvals. For instance, in February 2022, Olympus, a leading global technology company and provider of advanced solutions for medical and surgical procedures, has received approval from the Food and Drug Administration (FDA) for its CELERIS single-use sinus debrider device. The product is expected to be widely accessible in the market shortly.
Surge in launch of advanced sinus dilation devices is predicted to boost the market growth during the forecast period. The introduction of advanced surgical techniques contributes to enhanced market dynamics by replacing traditional procedures. Hence, these product launches contribute to increased availability and demand, thereby stimulating market growth. In March 2022, Medtronic plc has unveiled the NuVent Eustachian tube dilation balloon, which has received clearance from the U.S. Food and Drug Administration (FDA) for addressing chronic, obstructive Eustachian Tube Dysfunction. The NuVent balloon allows surgeons to administer treatment in either an outpatient or office environment.
By product, balloon sinus dilation (BSD) devices was the highest revenue-grossing segment in the global sinus dilation devices market in 2023 owing to the growing adoption of balloon sinus dilation procedures, an increase in the incidence of sinus infections, advancements in technology, ongoing research and development activities, and a rise in regulatory approvals. For instance, in May 2022, Dalent Medical has obtained additional patent coverage for its Sinusleeve balloon device, providing further safeguarding for the company's exclusive device and technique employed in balloon sinus dilation procedures aimed at treating chronic sinusitis. Additionally, functional endoscopic sinus surgery (FESS) instruments set is predicted to grow at fastest CAGR during the forecast period. The procedure is designed to address recurrent acute rhinosinusitis and medically refractory chronic rhinosinusitis, both with or without polyps. Known for its minimally invasive nature, it is widely preferred over alternative procedures, contributing to the anticipated growth of this segment.
By type, sinuscopes was the highest revenue-grossing segment in the global sinus dilation devices market in 2023 owing to the increasing favouritism towards minimally invasive procedures and advancements in sinuscope technology. Additionally, rhinoscopes is predicted to grow at fastest CAGR during the forecast period owing to the growing technological developments and surge in launch of advanced devices. For instance, in February 2023, Innovia Medical is pleased to introduce the Summit Medical ENT product line in the United Kingdom. This range includes a variety of high-quality essentials such as Grommets and Ventilation Tubes, Rhino Rocket, AbsorbENT Nasal and Sinus Packs, and Denver Splint. Healthcare providers in clinics and hospitals across the United States frequently use these products.
By procedure, standalone was the highest revenue-grossing segment in the global sinus dilation devices market in 2023 owing to the growing inclination toward minimally invasive surgical procedures is attributed to the increased adoption of health insurance. Balloon sinus ostial dilation is conducted independently as a standalone procedure, proving to be as effective as functional endoscopic sinus surgery in treating chronic rhinosinusitis. Additionally, hybrid is predicted to grow at fastest CAGR during the forecast period owing to the rising inclination toward hybrid procedures for both adult and pediatric patients, and an increase in regulatory approvals. For instance, in Aug 2022, Acclarent Inc, a subsidiary of Johnson & Johnson Medical Devices specializing in minimally invasive ENT technologies, has received clearance from the U.S. Food and Drug Administration for its TruDi shaver blade. TruDi is a single-use blade with electromagnetic navigation capabilities, designed for the removal or incision of tissues or bones in the field of Ear, Nose, and Throat (ENT).
By application, adult was the highest revenue-grossing segment in the global sinus dilation devices market in 2023 owing to the high incidence of sinusitis in adults, and increasing mergers & acquisitions among market players. For instance, in May 2022, Medtronic has finalized the acquisition of Intersect ENT, enhancing its ear, nose, and throat (ENT) portfolio with innovative products utilized in sinus procedures. Additionally, pediatric is predicted to grow at fastest CAGR during the forecast period owing to the growing occurrence of sinusitis among children, and various market players are concentrating on the development of products specifically tailored for pediatric patients.
By end-user, hospitals was the highest revenue-grossing segment in the global sinus dilation devices market in 2023 owing to the high volume of surgical procedures, attributed to factors such as the increasing prevalence of chronic sinusitis, favorable reimbursement criteria, the presence of technologically advanced infrastructure and medical equipment enabling the performance of complex sinus surgeries, and a rise in funding from major market players. For instance, in May 2022, The NHS has declared a MedTech funding mandate to enhance the availability and affordability of specific medical devices for patients. Among the supported products in this initiative is the XprESS multi-sinus dilation system by Stryker. This strategic support aims to encourage the adoption of this technology, granting the company a competitive edge in the European market. This initiative not only facilitates broader distribution of Stryker's dilation devices but also reinforces the company's brand presence. Additionally, ambulatory surgical centers (ASCs) is anticipated to grow at fastest CAGR during the forecast period. The healthcare system is showing interest in Ambulatory Surgical Centers (ASCs) as a strategic choice for providing surgical services. Minimally invasive procedures, including Balloon Sinus Dilation (BSD), can be conveniently performed in ASCs. Additionally, the anticipation of cost-effectiveness and more favorable reimbursement scenarios compared to hospitals is expected to drive the growth of this segment.
North America region is anticipated for the highest revenue share during the forecast period owing to the existence of a well-established healthcare infrastructure, a substantial burden of sinusitis and associated diseases, the introduction of new products, a heightened prevalence of risk factors contributing to sinusitis, including increased tobacco use and smoking, and a notable increase in approvals by regulatory authorities. For instance, in July 2022, Zsquare, a company specializing in high-performance, disposable endoscopes, has obtained FDA 510K clearance for its inaugural product, the Zsquare ENT-Flex Rhinolaryngoscope. The company intends to conduct a pilot launch of this product in prominent hospitals and physician practice offices across the United States by the fourth quarter of 2022. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the healthcare infrastructure that is both highly regulated and well-developed, a notable increase in patient awareness regarding sinus surgical procedures, continuous technological advancements, and a growing number of regulatory approvals. For instance, in February 2022, Olympus, a leading global technology company and provider of advanced solutions for medical and surgical procedures, has received approval from the Food and Drug Administration (FDA) for its CELERIS single-use sinus debrider device. The product is expected to be widely accessible in the market shortly.
Segmentation: Sinus Dilation Devices Market Report 2023 - 2034
Sinus Dilation Devices Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Functional Endoscopic Sinus Surgery (FESS) Instruments Set
- Ballon Sinus Dilation (BSD) Devices
- Sinus Stents/Implants
- Endoscopes
- Others
Sinus Dilation Devices Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)
- Rhinoscopes
- Sinuscopes
Sinus Dilation Devices Market Analysis & Forecast by Procedure 2023 - 2034 (Revenue USD Bn)
- Hybrid
- Standalone
Sinus Dilation Devices Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Pediatric
- Adult
Sinus Dilation Devices Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Ambulatory Surgical Centers
- Hospitals
- ENT Clinics/In Office
Sinus Dilation Devices Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Sinus Dilation Devices Market: Product Estimates & Trend Analysis
8. Sinus Dilation Devices Market: Type Estimates & Trend Analysis
9. Sinus Dilation Devices Market: Procedure Estimates & Trend Analysis
10. Sinus Dilation Devices Market: Application Estimates & Trend Analysis
11. Sinus Dilation Devices Market: End-user Estimates & Trend Analysis
12. Regional Market Analysis
13. North America Sinus Dilation Devices Market
14. Europe Global Sinus Dilation Devices Market
15. Asia Pacific Global Sinus Dilation Devices Market
16. Latin America Global Sinus Dilation Devices Market
17. MEA Global Sinus Dilation Devices Market
18. Competitor Analysis
19. Company Profiles
Companies Mentioned
- Johnson & Johnson Services Inc.
- Intersect ENT Inc
- SinuSys Corporation
- Medtronic
- InnAccel Technologies Pvt Ltd
- Stryker
- Olympus Corporation
- TE Connectivity
- Smith+Nephew
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 3.06 Billion |
| Forecasted Market Value ( USD | $ 8.43 Billion |
| Compound Annual Growth Rate | 9.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
